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ABSTrACT
This research assessed the impact of flunixin meglumine (FM) co-administration on the elimination and 
milk residual properties of oxytetracycline (OTC) in dairy goats. OTC was administered via single intravenous 
(i/v) and intramuscular (i/m) injections at a dose of 10 mg/kg body mass (b.m.). Serum, urine, milk and ruminal 
juice were analysed using high-performance liquid chromatography (HPLC). The OTC serum concentrations 
were higher than the MIC for 12 hours against most susceptible pathogens in both groups. The half-lives of 
the distribution (T1/2α) and elimination (T1/2β) of OTC were 0.24 and 5.79 hours, respectively. The total body 
clearance was significantly increased in the FM coadministered groups. Following i/m injection, the absorption 
half-life (T1/2ab) with the maximum absorption time (Tmax) revealed a rapid absorption rate. Furthermore, the 
systemic bioavailability (F%) after i/m was 107.2%, indicating complete absorption from the muscular tissues. 
The bounded fraction of OTC with serum proteins was 18.73%. FM significantly decreases OTC concentration 
in milk and ruminal juice. OTC is eliminated primarily through the kidneys and to a lesser extent via milk and 
ruminal juice in dairy goats. Milk obtained from OTC treated goats may not be safe for human consumption 
two days post administration. Concomitantly, the use of FM with OTC may necessitate the surveillance and 
optimization of OTC dosage.
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Introduction 
Newly combined formulations of antimicrobials with non-steroidal anti-inflammatory 
drugs (NSAIDs) have serious effects on elimination and residual patterns, especially 
in milk-producing animals. Information on milk residual patterns in these veterinary 
combinations is lacking (GROPPO et al., 2004; TSIVOU et al., 2005). Antibiotic residues 
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in animal products may significantly enhance the transfer of bacterial resistance to humans, 
potentially resulting in the failure of antimicrobial therapy in human (ATTAIE et al., 2016). 
The effect of this interaction on withdrawal times in dairy animals has not been confirmed 
(KUKANICH et al., 2005). Oxytetracycline (OTC) is a wide-spectrum chemotherapeutic 
agent that works against most pathogenic bacteria and certain other blood protozoal 
parasites (GIGUÈRE et al., 2013). In veterinary medicine, OTC is extensively used due 
to its broad-spectrum activity and appropriate tissue-penetrating aspects (GRAIGMILL et 
al., 2000). NSAIDs are commonly used with antibacterials to combat systemic infections 
associated with febrile diseases (MESTORINO et al., 2007). Flunixin meglumine (FM) 
is a NSAID and is a very potent inhibitor of the enzyme prostaglandin cyclooxygenase 
(COX), resulting in the inhibition of prostaglandin synthesis (LANDONI et al., 1995). 
Co-administration of FM and the broad-spectrum antibiotic OTC provided a greater 
benefit in pneumonia and in field cases of acute respiratory diseases (DOHERTY et al., 
2001). Previous studies reported on the pharmacokinetic interactions between FM with 
fluoroquinolones and cephalosporins when used concomitantly (LOCKWOOD et al., 
2003; HALLOY et al., 2006). Nevertheless, there is inadequate information on the effects 
of FM on the different elimination pathways and milk residues of OTC, especially in 
dairy animals. The aim of the present study was to evaluate the influence of concomitant 
administration of FM on the elimination patterns of OTC from the kidneys, milk and 
ruminal juice after i/v and i/m co-administration in dairy goats. Moreover, the milk 
withdrawal time of OTC in dairy goats was estimated.
Materials and methods
Drugs. Oxytetracycline (Terramycin®100): is an injectable preparation containing 
100 mg/mL OTC hydrochloride as a magnesium complex in aqueous solution. The drug 
is supplied by Pfizer, Egypt and is indicated for intramuscular and intravenous injection. 
Flunixin meglumine (Finadyne®): is a product of Schering - Plough, U.S.A., available 
as a sterile injection at 50 mg/mL. 
Oxytetracycline - flunixin combination: For every 100 mL of Pfizer Terramycin (100 
mg/mL) 40 mL of FM weas added as (50 mg/mL) to obtain a ratio of (10 mg OTC + 2 mg 
FM) for intravenous and intramuscular injection. No incompatibility was observed with 
the addition of FM.
Animals. Ten clinically healthy dairy goats of 2-2.5 years weighing 25-30 kg each, 
were used. The animals were fed a drug-free diet and water ad libitum in a hygienic 
environment and each goat was thoroughly milked twice daily. The institutional animal 
care and use committee (IACUC) of Cairo University approved the study (Feb-2017).
Experimental plan and sampling. The goats were divided into two groups (five goats 
each). Blood, urine, milk and ruminal juice samples free of drugs were collected before 
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drug administration. The goats were left for 30 days between each injection to ensure the 
complete elimination of the drugs. 
Intravenous (i/v) injection. Each of the 5 goats was injected with OTC (10 mg/kg 
b.m.) in the right jugular vein. Forty-five days later, these animals were injected with the 
same dose of OTC in combination with FM at a dose of 12 mg/kg b.m. via the same route.
Intramuscular (i/m) injection. The same doses of OTC and OTC + FM combination 
were injected into the left gluteal muscle with an interval of forty-five days in between.
Blood samples. Two millilitres of blood was collected from the left jugular vein via 
catheters just before and at 5, 10, 20, and 30 minutes and, 1, 2, 4, 6, 8, 10, 12, 24, 48 
and 72 hours after drug administration. Blood samples were allowed to clot at room 
temperature and the sera were separated by centrifugation at 3000 r.p.m. for 25 minutes, 
and stored at -20 0C until assayed.
Urine samples. Urine samples were collected using rubber balloon catheters fixed 
inside the bladder, that allowed urine to flow. The bladder was emptied before drug 
administration, and urine samples were collected 15 and 30 minutes and, 1, 2, 4, 6, 8, 
10, 12, 24, 48 and 72 hours. post-injection. The urine samples taken at 15 minutes were 
discarded. All urine samples were stored at -20 0C until assayed. 
Milk samples. Samples were collected by hand milking. The udder was completely 
evacuated before the injection and after each sampling. Samples were taken at 15 and 30 
minutes and, 1, 2, 4, 6, 8, 10, 12, 24, 48 and 72 hours following drug administration. The 
milk samples taken at 15 minutes were discarded. Complete evacuation of the udder was 
carried out after each sampling.
Ruminal juice samples. Samples were obtained via a stomach tube connected to a 
vacuum pump. Samples were taken before and 1, 2, 4, 6, and 8 hours after the injections.
Analytical procedure. The concentrations of OTC in the serum and different body fluids 
were analyzed using HPLC (Shimadzu modular system - Japan) with the reversed-phase 
separation method of KNOX and JAURAND (1979). The mobile phase was composed 
of 30% N, N-dimethyl formamide and 70% water containing sodium citrate (0.013 M), 
potassium nitrate (0.01 M), disodium EDTA (0.001 M) and citric acid monohydrate (0.05 
M) with the pH adjusted to 3.5 using phosphoric acid. The mobile phase was degassed 
using an ultrasonic cleaner (Bransonic, USA) for one hour. The flow rate was 0.5 mL/
min. The concentrations were detected at 365 nm with an ultraviolet detector.
Sample preparation. One mL of sample was deproteinated with 0.25 mL of 15% 
trichloroacetic acid, according to ASZALOS, 1985. The mixture was vortexed for one 
minute, placed on ice for 15 minutes and centrifuged for 15 minutes at 3000 r.p.m. 
Methanol was added to the milk samples (1:1), and the mixture was vortexed for one 
minute, placed on ice for 15 minutes and centrifuged at 3000 r.p.m. for 30 minutes. Urine 
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samples were diluted to 1:10 using HPLC-grade water, and then 0.5 mL of the supernatant 
was mixed with an equal volume of methanol and centrifuged for 20 minutes. Ruminal 
juice samples were centrifuged at 3000 r.p.m. for 30 minutes. Twenty microlitres of the 
clear supernatant was diluted with 0.8 mL of HPLC-grade water, mixed and centrifuged, 
and 0.5 mL of the supernatant, with an equal volume of methanol, was centrifuged for 15 
minutes. Twenty microlitres of the clear supernatant was injected into the HPLC column 
from all types of samples. 
Validation of the analytical method. The precision and accuracy of the method were 
evaluated by repetitive analysis of the different samples (n = 6), spiked with different, 
known concentrations of OTC. Intra-assay variations were determined by measuring six 
replicates (n = 6) of three standard samples used for calibration curves. The calibration 
curve provided excellent linearity with correlation coefficients (r2) of > 0.98 in the present 
study, and the linearity was confirmed by the test of lack of fit (P = 0.756). The intra-assay 
variation coefficient (CV) was 4%. Inter-assay precision was determined by assaying 
three standard samples on three separate days. The inter-assay CV was <5% for serum. 
Recovery of OTC from all samples was found to be 96%. The limit of detection (LOD) 
and limit of quantification (LOQ) of OTC were 0.005 and 0.01 µg/mL, respectively.
Estimation of protein binding. After the protein-bound part is precipitated in the 
serum, the free unbound drug is the part that part that is measured by HPLC and gives 
the measured area under the curve. Differences in the area under the curve between the 
solution of OTC alone or combined with FM in phosphate buffer, and that of serum at the 
same concentrations were used to calculate the protein binding affinity of OTC according 
to CRAIG and SUH (1980).
Pharmacokinetic analysis. A computerized curve-stripping program (Rstrip, 
Micromath, Scientific Software, Salt Lake City, Utah, USA) was used for data analysis 
for each animal. Following intravenous injection, the disposition curves of OTC that 
express the decline in serum drug concentration as a function of time was best described 
by the two-compartmental open model (biexponential expression):
Cp = Ae-αt + Be -βt
where 
Cp is the drug concentration in serum at time t; 
A and B are the intercepts of the distribution and elimination phases, respectively, 
with the concentration axis expressed as µg/ mL; 
α and β are the distribution and elimination rate constants, respectively expressed in 
units of reciprocal time (h-1); 
e is the natural logarithm base.
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The apparent volume of distribution was calculated according to BAGGOT (1977) 
via the area (Vdarea), and steady state (Vdss) methods.
Following i/m injection, the peak of OTC concentration (Cmax) and time to peak 
concentration (Tmax) were determined. This program also calculated non-compartmental 
parameters by using the statistical moment theory. The elimination half-life (T½el) was 
calculated as ln2/β. The areas under the concentration-time curves (AUC) were calculated 
according to the trapezoidal rule (GIBALDI and PIERRIER, 1982). The mean residence 
time (MRT) for OTC was calculated as AUMC/AUC, where AUMC is the area under 
the first moment curve and AUC is the area under the curve. The systemic bioavailability 
is the fraction of the intramuscular dose absorbed, and is calculated as F% = (AUCi/m/
AUCi/v) × 100.
The body clearance (Cltot) is the volume of blood cleared of the drug by various 
elimination processes (biotransformation and excretion) per unit of time, and is calculated 
as follows: 
Cltot = K
el X Vc  L kg-1 h-1
Statistical analysis. The results are tabulated as the mean ± SE. The significance of 
differences between the mean concentrations and kinetic parameters of the groups treated 
with the combination, and those given the antibiotic alone were analysed statistically 
using Student’s t-test in SPSS 16.0 (SPSS Inc., Chicago, IL, USA).
results
The mean serum concentration-time curves for OTC after i/v and i/m injections, 
either alone or combined with FM, are presented in Figs 1 and 2. The pharmacokinetic 
values following intravenous injection are summarized in Table 1. Following i/v 
injection, the OTC serum concentration declined in a biexponential mode, indicating the 
distribution and elimination phases and mitigating the best choice of a two-compartment 
model for analysis. The half-lives of the distribution and elimination of OTC were 
significantly decreased with co-administration of FM. Furthermore, the apparent volumes 
of distribution of OTC combined with FM showed values half of those calculated after 
OTC administration alone. The pharmacokinetic parameters of OTC after i/m injection 
(Table 1) showed a comparatively narrow variation between the single and combined 
formulation with FM, versus the case of intravenous administration. OTC was largely 
eliminated in urine after both single and combined administration with FM (Table. 2). 
However, the tested drug was excreted in small concentrations in the ruminal juice and 
milk, with comparatively higher values in both fluids after the sole administration of OTC 
than in OTC combined with FM (Tables 3 and 4).
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Fig. 1. Serum concentrations of oxytetracycline (10 mg/kg b.m.) following single intravenous 
injection alone and with flunixin meglumine (12 mg/kg b.m.) coadministration in dairy goats
Fig. 2. Serum concentrations of oxytetracycline (10 mg/kg b.m.) following single intramuscular 
injection alone and with flunixin meglumine (12 mg/kg b.m.) coadministration in dairy goats
Table 1. Mean kinetic parameters of OTC alone (10 mg/kg b.m.) and OTC + flunixin combination 
(12 mg/kg b.m.) following single intravenous and intramuscular injections in goats (n = 5)
Parameter Unit
Intravenous Intramuscular
OTC OTC + FM OTC OTC + FM
α (kab) h-1 2.95 ± 0.048 4.22 ± 0.38** 1.06 ± 0.02 0.91 ± 0.018**
T1/2α (T1/2ab) h 0.24 ± 0.0096 0.19 ± 0.001*** 0.65 ± 0.017 0.75 ± 0.0184*
Β (Kel) h-1 0.12 ± 0.00014 0.29 ± 0.033** 0.05 ± 0.0028 0.11 ± 0.006***
T1/2β(Tel) h 5.79 ± 0.066 2.43 ± 0.22*** 13.3 ± 1.4 6.21 ± 0.45***
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OTC OTC + FM OTC OTC + FM
K12 h-1 1.87 ± 0.04 3.26 ± 0.019** NA NA
K21 h1 0.61 ± 0.017 1.35 ± 0.1** NA NA
Vc L.kg-1 0.29 ± 0.004 0.23 ± 0.0021 NA NA
Cmax µg/mL NA NA 3.17 ± 0.12 3.79 ± 0.2*
Tmax h NA NA 2.76 ± 0.23 2.68 ± 0.04
Vd(area) L.kg-1 1.63 ± 0.0114 0.72 ± 0.026*** NA NA
Vd(ss) L.kg-1 1.13 ± 0.0081 0.61 ± 0.03*** NA NA
Cltot L h-1kg-1 0.16 ± 0.0001 0.20 ± 0.007*** NA NA
AUC µg.mL.h-1 63.2 ± 0.72 47.5 ± 1.58** 68.6 ± 3.1 46.4 ± 2.4***
MRT h 6.75 ± 0.009 3.01 ± 0.118*** 19.07 ± 1.2 9.04 ± 0.5***
F % NA NA 107.2 ± 3.3 97.29 ± 5.1
α - distribution rate constant; β - rapid elimination rate constant; kab - absorption rate constant; kel - elimination 
rate constant kel; T1/2α - distribution half-life; T1/2ab - absorption half-life; T1/2β rapid elimination half-life; T1/2el 
- elimination half-life; K12 and K21 - first-order rate constants for drug distribution between the central and 
shallow peripheral compartments; Vc - volume of the central compartment; Cmax - peak drug concentration; 
Tmax - time to peak concentration; Vd(area) - volume of distribution calculated by area method; Vd(SS) volume of 
distribution at steady state; Cltot - total body clearance; AUC - area under the curve from zero to infinity by 
the trapezoidal integral; MRT - mean residence time in serum; and F - the systemic bioavailability. NA; not 
applicable; *Significant at P≤0.05; **Significant at P≤0.01; ***Significant at P≤0.001.
Table 2. Mean concentration of OTC (µg/mL) ± SE in urine following single intravenous and 
intramuscular injection of OTC (10 mg/kg b.m.) and OTC + FM combination (12 mg/kg b.m.) in 




(OTC) (OTC + FM) (OTC) (OTC + FM)
30 min 731 ± 35 851 ± 29* 126.9 ± 5.006 221 ± 20.4**
1 h 528.5 ± 15.6 610 ± 22.4** 210.4 ± 14.36 390 ± 30.0***
2 h 318 ± 16.8 407 ± 26.0* 263.4 ± 23.2 430 ± 32**
4 h 191.6 ± 15 210 ± 20 313 ± 26.5 570 ± 21***
6 h 152.6 ± 12.4 130 ± 11 248.8 ± 22.4 490 ± 40***
8 h 131 ± 7.60 105 ± 6.4* 230 ± 29.5 330 ± 22*
10 h 95 ± 8.40 66 ± 5.2* 224 ± 21.8 250 ± 20
12 h 61.4 ± 4.20 44 ± 4.2* 197 ± 8.1 170 ± 7.2*
24 h 23 ± 2.10 17 ± 1.2* 60.4 ± 5.3 45 ± 3.0*
48 h 12 ± 1.10 6 ± 0.35*** 16.6 ± 1.9 10 ± 0.98*
72 h 2.0 ± 0.10 0.5 ± 0.039*** 5.4 ± 0.45 2.5 ± 0.1***
*Significant at P≤0.05 **Significantat P≤0.01; ***Significant at P≤0.001
Table 1. Mean kinetic parameters of OTC alone (10 mg/kg b.m.) and OTC + flunixin combination 
(12 mg/kg b.m.) following single intravenous and intramuscular injections in goats (n = 5) (continued)
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Table 3. Mean concentration of OTC (µg/mL) ± SE. in milk following single intravenous and 
intramuscular injection of OTC (10 mg/kg b.m.) and OTC + FM combination (12 mg/kg b.m.) in 




(OTC) M/S (OTC + FM) M/S (OTC) M/S (OTC + FM) M/S
30 min 0.79 ± 0.04 0.07 0.10 ± 0.009*** 0.01 0.40 ± 0.02 0.21 0.14 ± 0.01*** 0.05
1 h 1.36 ± 0.02 0.22 0.40 ± 0.021*** 0.05 0.57 ± 0.04 0.22 0.40 ± 0.02** 0.14
2 h 1.51 ± 0.03 0.27 0.58 ± 0.037*** 0.09 0.70 ± 0.04 0.23 0.58 ± 0.03* 0.16
4 h 1.91 ± 0.03 0.41 0.94 ± 0.035*** 0.27 1.59 ± 0.06 0.53 0.67 ± 0.03*** 0.17
6 h 2.06 ± 0.07 0.58 1.13 ± 0.10*** 0.46 1.95 ± 0.0 0.66 1.08 ± 0.09*** 0.34
8 h 1.46 ± 0.05 0.56 0.80 ± 0.04*** 0.65 2.10 ± 0.06 0.83 1.19 ± 0.03*** 0.48
10 h 1.20 ± 0.04 0.77 0.58 ± 0.03*** 0.73 1.80 ± 0.10 0.91 0.70 ± 0.03*** 0.39
12 h 1.16 ± 0.11 0.86 0.3 ± 0.025*** 0.60 1.20 ± 0.02 1.09 0.40 ± 0.02*** 0.27
24 h 0.70 ± 0.05 ND 0.96 ± 0.03 0.90 0.17 ± 0.01*** 0.44
48 h --------- ND 0.36 ± 0.03 ND
*Significant at P≤0.05; **Significantat P≤0.01; ***Significant at P≤0.001; ND - not detected
Table 4. Mean concentration of OTC (µg/mL) ± S.E. in ruminal juice following single intravenous 
and intramuscular injection of OTC (10 mg/kg b.m.) and OTC + FM combination (12 mg/kg 




(OTC) R/S (OTC + FM) R/S (OTC) R/S (OTC + FM) R/S
1 h 7.6 ± 0.4 1.22 4.97 ± 0.39*** 0.46 1.2 ± 0.09 0.45 0.7 ± 0.02*** 0.24
2 h 6.1 ± 0.5 1.07 3.72 ± 0.25*** 0.59 1.9 ± 0.1 0.64 1.3 ± 0.1** 0.36
4 h 4.5 ± 0.19 0.97 3.5 ± 0.27* 1.01 2.3 ± 0.2 0.76 1.9 ± 0.12 0.49
6 h 4.0 ± 0.25 1.13 3.0 ± 0.15* 1.23 2.9 ± 0.02 0.98 2.3 ± 0.2* 0.72
8 h 3.1 ± 0.29 1.19 2.8 ± 0.1 2.26 1.6 ± 0.15 0.63 1.3 ± 0.01* 0.52
*Significant at P≤0.05; **Significantat P≤0.01; ***Significant at P≤0.001
discussion
The OTC serum concentrations after i/v injection of either alone or in combination 
with FM in dairy goats were best depicted by the two compartments open model, 
which is consistent with previous studies on OTC in goats (ESCUDERO et al., 1994; 
ELSHEIKH et al., 1997). However, a few authors have reported that OTC fitted into a 
three-compartment model in veal calves (MEIJER et al., 1993). In the present study, the 
therapeutic level of OTC estimated in the blood of goats overlapped its MIC 0.5 mg/l 
(LUTHMAN and JACOBSSON, 1982) for more than 24 hours when injected either alone 
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or in combination with FM. This result is in agreement with those reported for OTC when 
co-administered with diclofenac in cattle (MESTORINO et al., 2007). The volumes of 
distribution of OTC in the central compartment Vc, were 0.28 and 0.23 L/kg for OTC 
alone and in combination with FM, respectively. These values are close to those reported 
in cows of 0.24 L/kg (BRETZALFF et al., 1982) and are lower than that recorded in 
goats of 0.45 L/kg (ELSHEIKH et al., 1997). The high Vd values of OTC indicated that 
the drug is highly distributed in the extravascular tissues. However, the (Vdarea) and 
(Vdss) for OTC combined with FM reported in the present study (0.72 and 0.61 L/kg 
respectively) are significantly lower than those of OTC alone. Similar observations were 
reported when FM was given with sulphadimidine in horses (EL BANNA, 1999). 
The elimination half-life (T1/2β) of OTC alone (5.79 h) was higher than that of OTC 
combined with FM (2.43 h). The value of (T1/2β) for OTC alone is similar to that reported 
in cows (BRETZALFF et al., 1982) and goats (ELSHEIKH et al., 1997). The mean AUC, 
MRT and Vd were considerably reduced, although the total body clearance was increased 
in FM-treated-groups. As NSAIDs inhibit prostaglandin synthesis in the body, they may 
modify the renal excretion of other drugs administered. Thus, the renal blood flow and 
renin release are altered, and the rate of elimination is changed (VERBEECK, 1990). 
The peaks of OTC serum concentration after i/m injection were 3.17 and 3.79 µg/mL 
and were attained at nearly Tmax (2.68 and 2.76 h alone and with FM, respectively). Co-
administration of FM significantly shortened the T1/2el and MRT of OTC (6.21 and 9.04 h, 
respectively) versus those of OTC alone (13.3 and 19.07 h, respectively). The plasma peak 
time recorded in this study was close to that previously reported in goats (ELSHEIKH et 
al., 1997). The OTC serum concentrations were higher than the MIC for 12 hours against 
most susceptible pathogens in both groups. FM increased the OTC concentrations after 
i.m injection during the first four hours sampling. This finding supported the results of 
TSIVOU et al. (2005), who showed that the NSAIDs diclofenac and ibuprofen raised 
the blood levels of cephalosporins. The authors explained this finding on the basis of 
the greater serum and tissue proteins binding affinity of NSAIDs than cephalosporins. 
Therefore, NSAIDs apparently have an antagonistic effect on binding ability, resulting 
in higher concentrations of free antibiotics in the blood, consequently enhancing their 
metabolism and elimination. The systemic bioavailability (F%) scores of OTC after 
i/m injections alone or with FM in dairy goats were 107.2% and 97.29% respectively, 
suggesting excellent absorption from the site of injection. These results were close to 
those reported by McELROY et al. (1987) in rabbits, but higher than those reported by 
ESCUDERO et al. (1994) in goats. Regarding the effect of FM on the kinetic disposition 
of OTC, our results are consistent with those reported previously (GROPPO et al., 2004; 
ABO-EL-SOOUD and AL-ANATI, 2011) concerning the effects of NSAIDs on the 
disposition kinetics of various antibacterials.
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The bounded fraction of OTC with serum proteins was 18.73%, indicating that OTC 
binds loosly in blood albumen in goats. This leads to an increase in free OTC levels, 
which increases their distribution and excretion processes. The increased elimination 
and reduction values of MRT of OTC after its concurrent injection with FM could be 
explained by the findings in TSIVOU et al. (2005), and may be attributed to the increased 
level of OTC due to its displacement from protein-bound sites in the presence of FM.
Approximately 70% of the dose is eliminated in urine. The increased urinary 
concentration of OTC indicates that it has higher efficacy against pathogenic organisms 
invading the urinary tract of diseased animals. The use of FM in combination with OTC 
did not alter the duration of its antibacterial activity (>0.5 μg/mL for most susceptible 
bacteria) in goat’s urine (72 h. following i/v and i/m injections of both treatments). 
The concomitant use of OTC and FM is more favourable for urinary tract pathogens in 
ruminants, as confirmed by the present findings. In this respect, MEVIUS et al. (1986) 
found that approximately 88.0% of the OTC dose administered was eliminated from 
the kidneys within 72 h. Moreover, they reported that the OTC clearance was twice as 
great as creatinine clearance, showing that glomerular filtration is the main pathway of 
elimination of OTC followed, to a lesser extent, by tubular secretion. 
The concentrations of OTC in the milk were much lower than those in the urine. FM 
induced a significant reduction in the concentrations of OTC in milk. Drugs cross the 
blood-milk barrier by passive diffusion according to the physicochemical properties of 
the drug (ATKINSON and BEGG, 1990). In addition, the low lipophilicity of OTC delays 
its passage through lipid layers of blood-milk barriers, and its passage is mainly through 
large pores. MEVIUS et al. (1986) stated that less than 2% of the dose administered was 
excreted in milk.
The presence of OTC residues in milk interferes with the manufacturing of dairy 
products by inhibiting starter activity, which can lead to economic losses (HAYS, 
2003). The existence of measurable OTC residues in milk was detected two days after 
i/m administration. A parallel finding was reported by RULE et al. (2001) in healthy 
Murciano-Granadina goats.
 The present investigation revealed that OTC concentrations were detected in ruminal 
juice for 8 hours after administration via both routes. As in the milk, the concomitant 
administration of FM with OTC induced a significant reduction in ruminal juice 
concentrations of OTC. The explanation for this observation may be similar to that for 
the OTC concentrations in milk, with the acidic pH of ruminal juice (pH 6.3) leading to 
a subsequent increased back diffusion of the drug to the blood. The lower concentration 
of OTC in the ruminal juice of animals treated with the OTC + FM combination is more 
beneficial than in goats treated with OTC alone, due to the reduced inhibitory effect of 
the former on ruminal microflora. The relatively higher OTC concentration in ruminal 
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juice than in milk could be attributed to the additional excretion of OTC in saliva (ATEF 
et al., 1981).
In conclusion, OTC is eliminated primarily through the kidneys and, to a lesser extent, 
via milk and ruminal juice in dairy goats. Milk obtained from OTC-treated goats may not 
be safe for human consumption for two days post-administration. Concomitantly, the 
use of FM with OTC may necessitate the surveillance and optimization of OTC dosages. 
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SAžETAK
Istražen je utjecaj fluniksina-meglumina (FM) na uklanjanje i rezidualna svojstva oksitetraciklina (OTC) 
u mlijeku mliječnih pasmina koza. OTC je dan jednokratno intravenski i intramuskularno u dozi od 10 mg/
kg tjelesne mase. Serum, urin, mlijeko i buražni sok analizirani su tekućinskom kromatografijom visoke 
učinkovitosti (HPLC). Koncentracije OTC u serumu bile su tijekom 12 sati više od najmanje inhibitorne 
koncentracije za najosjetljivije patogene u objema skupinama. Vrijeme polurazgradnje OTC-a (T1/2α) bilo je 
0,24 sata, a vrijeme uklanjanja (T1/2β) 5,79 sati. Vrijeme potpunog uklanjanja OTC-a statistički znakovito je 
poraslo u skupinama kojima je istodobno dan i fluniksin-meglumin. Nakon intramuskularne injekcije poluvijek 
apsorpcije (T1/2ab) s maksimalnim vremenom apsorpcije (Tmax) pokazao je veću brzinu apsorpcije. Osim toga 
sistemska bioraspoloživost (F %) nakon intramuskularne primjene bila je 107,2 % što upućuje na potpunu 
apsorpciju iz mišićnih tkiva. Dio OTC-a vezan na serumske proteine iznosio je 18,73 %. Fluniksin-meglumin 
statistički znakovito je smanjio koncentracije OTC-a u mlijeku i buražnom soku. OTC je uklonjen ponajprije 
putem bubrega i, u manjoj mjeri, mlijekom i buražnim sokom u mliječnih pasmina koza. Mlijeko dobiveno od 
koza kojima je davan OTC nije prikladno za upotrebu u ljudi do dva dana nakon primjene. Istodobna primjena 
FM-a s OTC-om može zahtijevati praćenje i optimizaciju OTC doze.
Ključne riječi: oksitetraciklin; fluniksin-meglumin; uklanjanje; mlijeko; rezidue; koze________________________________________________________________________________________
